IDEXX Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . IDEXX Laboratories
IDXX Stock  USD 444.53  15.23  3.31%   
IDEXX Laboratories financial statements provide useful quarterly and yearly information to potential IDEXX Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on IDEXX Laboratories financial statements helps investors assess IDEXX Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IDEXX Laboratories' valuation are summarized below:
Gross Profit
2.4 B
Profit Margin
0.2278
Market Capitalization
36.4 B
Enterprise Value Revenue
9.488
Revenue
3.9 B
We have found one hundred twenty available fundamental trends for IDEXX Laboratories, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of IDEXX Laboratories regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself in the future. Market Cap is likely to rise to about 7 B in 2025. Enterprise Value is likely to rise to about 7.6 B in 2025

IDEXX Laboratories Total Revenue

4.09 Billion

Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 138.8 M, Interest Expense of 11 M or Total Revenue of 4.1 B, as well as many indicators such as Price To Sales Ratio of 9.17, Dividend Yield of 0.0 or PTB Ratio of 37.5. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.9 B3.7 B2 B
Slightly volatile
Other Current Liabilities449.6 M428.2 M267 M
Slightly volatile
Total Current Liabilities1.1 B1.1 B763.6 M
Slightly volatile
Property Plant And Equipment Net987.3 M940.3 M477.3 M
Slightly volatile
Accounts Payable133.6 M127.2 M71.5 M
Slightly volatile
Cash548.1 M522 M241.8 M
Slightly volatile
Non Current Assets Total2.1 B2 B1 B
Slightly volatile
Non Currrent Assets Other402.1 M382.9 M204.5 M
Slightly volatile
Cash And Short Term Investments548.1 M522 M287.8 M
Slightly volatile
Net Receivables639.4 M609 M301 M
Slightly volatile
Common Stock Shares Outstanding94.1 M83.1 M93 M
Slightly volatile
Liabilities And Stockholders Equity3.9 B3.7 B2 B
Slightly volatile
Inventory459.2 M437.3 M223.5 M
Slightly volatile
Other Current Assets158.8 M151.2 M103.1 M
Slightly volatile
Total Liabilities2.1 B2 B1.4 B
Slightly volatile
Total Current Assets1.8 B1.7 B915.3 M
Slightly volatile
Intangible Assets74.5 M97.2 M63.6 M
Slightly volatile
Short and Long Term Debt Total1.3 B1.2 B886.1 M
Slightly volatile
Short Term Debt211.6 M396.5 M354.7 M
Pretty Stable
Property Plant And Equipment Gross1.9 B1.8 B701.4 M
Slightly volatile
Common Stock Total Equity9 M12.3 M10 M
Slightly volatile
Common Stock9.2 M12.4 M10 M
Slightly volatile
Other Assets467.9 M445.6 M267.9 M
Slightly volatile
Property Plant Equipment784.2 M746.9 M444.1 M
Slightly volatile
Current Deferred Revenue25 M42.8 M30.8 M
Slightly volatile
Good Will441.9 M420.9 M248.1 M
Slightly volatile
Other Liabilities83.3 M122.6 M108.4 M
Slightly volatile
Long Term Debt380.8 M716.3 M478.1 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity853.7 K813 K365.9 K
Slightly volatile
Retained Earnings Total Equity4.3 B4.1 B2 B
Slightly volatile
Long Term Debt Total502 M798.5 M495.4 M
Slightly volatile
Capital Surpluse1.1 B1.7 B1.1 B
Slightly volatile
Deferred Long Term Liabilities7 M7.3 M33.3 M
Slightly volatile
Non Current Liabilities Other241.1 M229.6 M119.4 M
Slightly volatile
Short and Long Term Debt340.3 M292.5 M442.6 M
Slightly volatile
Long Term Investments67.9 M64.6 M23.8 M
Slightly volatile
Net Invested Capital1.6 B2.8 B1.4 B
Slightly volatile
Capital Stock11.7 M12.4 M10.8 M
Slightly volatile
Capital Lease Obligations115.7 M137.4 M95.2 M
Slightly volatile

IDEXX Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization138.8 M132.1 M82.2 M
Slightly volatile
Total Revenue4.1 B3.9 B2.3 B
Slightly volatile
Gross Profit2.5 B2.4 B1.3 B
Slightly volatile
Other Operating Expenses2.9 B2.8 B1.7 B
Slightly volatile
Operating Income1.2 B1.1 B567 M
Slightly volatile
EBIT1.3 B1.3 B580.2 M
Slightly volatile
EBITDA1.2 B1.1 B621.2 M
Slightly volatile
Cost Of Revenue1.6 B1.5 B954.6 M
Slightly volatile
Total Operating Expenses1.3 B1.3 B747.4 M
Slightly volatile
Income Before Tax1.2 B1.1 B545.3 M
Slightly volatile
Net Income932.3 M887.9 M429.1 M
Slightly volatile
Income Tax Expense233.1 M222 M116.2 M
Slightly volatile
Research Development230.8 M219.8 M132 M
Slightly volatile
Selling General Administrative464.4 M442.3 M249.4 M
Slightly volatile
Net Income Applicable To Common Shares820 M781 M407.1 M
Slightly volatile
Selling And Marketing Expenses307.4 M588.5 M355.7 M
Slightly volatile
Net Income From Continuing Ops993.4 M946.1 M452.9 M
Slightly volatile
Non Operating Income Net Other1.5 M958.5 K1.7 M
Slightly volatile
Non Recurring6.6 M7.4 M8.1 M
Slightly volatile
Tax Provision135 M243.8 M118 M
Slightly volatile
Interest Income3.7 M2 M11.3 M
Slightly volatile
Reconciled Depreciation107 M131 M93.8 M
Slightly volatile

IDEXX Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow476.6 M453.9 M214.4 M
Slightly volatile
Depreciation138.8 M132.1 M82.2 M
Slightly volatile
Capital Expenditures65.6 M120.9 M94.8 M
Slightly volatile
Total Cash From Operating Activities975.5 M929 M467.4 M
Slightly volatile
Net Income932.3 M887.9 M429.2 M
Slightly volatile
End Period Cash Flow151.8 M288.3 M202.5 M
Pretty Stable
Stock Based Compensation72.1 M68.7 M32.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.178.73077.8779
Slightly volatile
Operating Cash Flow Per Share11.8511.28745.376
Slightly volatile
Stock Based Compensation To Revenue0.00860.01470.0119
Slightly volatile
Capex To Depreciation1.751.341.8319
Slightly volatile
ROIC0.170.30.2478
Slightly volatile
Inventory Turnover2.973.484.319
Very volatile
Net Income Per Share11.3310.78774.9684
Slightly volatile
Payables Turnover10.6711.9713.4507
Pretty Stable
Sales General And Administrative To Revenue0.0880.11350.1065
Slightly volatile
Research And Ddevelopement To Revenue0.06940.05640.06
Pretty Stable
Capex To Revenue0.02950.0310.0629
Slightly volatile
POCF Ratio38.4636.628339.2936
Slightly volatile
Capex To Operating Cash Flow0.120.13020.3893
Slightly volatile
Income Quality0.791.04631.1544
Slightly volatile
PE Ratio23.6338.325343.091
Slightly volatile
Return On Tangible Assets0.140.270.2248
Slightly volatile
Earnings Yield0.03330.02610.0264
Slightly volatile
Intangibles To Total Assets0.20.160.1696
Pretty Stable
Current Ratio2.841.811.6127
Pretty Stable
Receivables Turnover5.866.227.6217
Pretty Stable
Capex Per Share1.541.46921.1091
Slightly volatile
Revenue Per Share49.7247.35525.9054
Slightly volatile
Debt To Assets0.20.290.4391
Very volatile
Days Sales Outstanding60.1660.7151.8594
Pretty Stable
EV To Sales12.0611.498.4661
Slightly volatile
Days Of Inventory On Hand12010989.3509
Very volatile
Cash Per Share5.164.923.0388
Slightly volatile
Days Payables Outstanding38.6131.5731.2386
Pretty Stable
EV To Operating Cash Flow48.746.3841.8311
Slightly volatile
Graham Number60.4457.5623.7475
Slightly volatile
Average Receivables211.8 M254.7 M256.3 M
Slightly volatile
Interest Debt Per Share12.6212.029.9536
Slightly volatile
Enterprise Value Over EBITDA36.2634.5330.2467
Slightly volatile
Short Term Coverage Ratios3.053.212.3741
Slightly volatile
Price Earnings Ratio23.6338.325343.091
Slightly volatile
Price To Operating Cash Flows Ratio38.4636.628339.2936
Slightly volatile
Pretax Profit Margin0.30.28480.2181
Slightly volatile
Ebt Per Ebit1.30.98361.0014
Very volatile
Operating Profit Margin0.30.28950.225
Slightly volatile
Effective Tax Rate0.210.20.2283
Slightly volatile
Long Term Debt To Capitalization0.30.270.5498
Pretty Stable
Total Debt To Capitalization0.280.380.6198
Very volatile
Return On Capital Employed0.260.430.4495
Slightly volatile
Ebit Per Revenue0.30.28950.225
Slightly volatile
Quick Ratio2.071.351.132
Pretty Stable
Dividend Paid And Capex Coverage Ratio8.077.68264.3958
Slightly volatile
Net Income Per E B T1.170.80.7954
Slightly volatile
Cash Ratio0.950.550.4414
Pretty Stable
Operating Cash Flow Sales Ratio0.120.23840.1842
Slightly volatile
Cash Flow Coverage Ratios0.930.980.7368
Pretty Stable
Fixed Asset Turnover7.045.155.0126
Slightly volatile
Capital Expenditure Coverage Ratio8.077.68264.3958
Slightly volatile
Price Cash Flow Ratio38.4636.628339.2936
Slightly volatile
Debt Ratio0.20.290.4391
Very volatile
Cash Flow To Debt Ratio0.930.980.7368
Pretty Stable
Price Sales Ratio9.178.73077.8779
Slightly volatile
Return On Assets0.240.230.1956
Slightly volatile
Asset Turnover0.861.011.1383
Very volatile
Net Profit Margin0.240.22780.1692
Slightly volatile
Gross Profit Margin0.610.61040.5722
Slightly volatile
Operating Cycle177169141
Pretty Stable
Days Of Payables Outstanding38.6131.5731.2386
Pretty Stable
Cash Conversion Cycle138138110
Very volatile
Days Of Inventory Outstanding12010989.3509
Very volatile
Days Of Sales Outstanding60.1660.7151.8594
Pretty Stable
Enterprise Value Multiple36.2634.5330.2467
Slightly volatile

IDEXX Laboratories Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7 B6.7 B6.9 B
Slightly volatile
Enterprise Value7.6 B7.2 B7.4 B
Slightly volatile

IDEXX Fundamental Market Drivers

Forward Price Earnings37.8788

IDEXX Upcoming Events

5th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue42.8 M25 M
Total Revenue3.9 B4.1 B
Cost Of Revenue1.5 B1.6 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.11  0.09 
Research And Ddevelopement To Revenue 0.06  0.07 
Capex To Revenue 0.03  0.03 
Revenue Per Share 47.35  49.72 
Ebit Per Revenue 0.29  0.30 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CSXCSX Corporation
ETONEton Pharmaceuticals
ALLTAllot Communications

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY